4.5 Review

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Palivizumab use in subjects with congenital heart disease

Stuart A. Cohen et al.

PEDIATRIC CARDIOLOGY (2008)

Article Pediatrics

Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing

Eric A. F. Simoes et al.

JOURNAL OF PEDIATRICS (2007)

Article Biochemistry & Molecular Biology

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)

William F. Dall'Acqua et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)